Dr. Stephen Paul Staal, MD

Dr. Staal practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Staal's NPI, 1194886564, was assigned on December 12, 2006. Dr. Staal graduated from UC San Diego School of Medicine in 1972. Dr. Staal holds Florida license ME99687.

Dr. Staal's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Staal's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Staal practices. Vendor and product names are available with a free account.

Medical oncology is Dr. Staal's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Staal is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Staal's licenses on file in 5 states: Florida, California, District of Columbia, Virginia and Maryland.

Dmand AI lists breast cancer, chronic leukemia, colorectal cancer, lung cancer, lymphoma and prostate cancer among the conditions Dr. Staal treats.

CMS data shows 748 Medicare services from Dr. Staal across 5 procedure codes in 2024, for 297 Medicare patients. Medicare paid $58,357 for them. Every service was in an office.

CMS counts 297 Medicare patients who saw Dr. Staal in 2024. The largest group is 65 to 74, with 133 patients. 71% of them have high cholesterol, and 70% have high blood pressure. 14% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Staal's median patient age at 74, with 55% women.

In 2024, Dr. Staal wrote 761 Medicare Part D claims for 136 patients. 64% of them were for generic drugs. CMS names the drug for 541 of them, across 19 drugs with 11 or more claims each, at $2,840,904 in total drug cost. In 2023, CMS named 457 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Staal for performance year 2024, reported through an alternative payment model (APM). Dr. Staal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 17 papers to Dr. Staal in 2009. The most frequent topics are Cell Line, DNA, Viral and Leukemia Virus, Murine. Dr. Staal has published most often in Proc Natl Acad Sci U S A. Dr. Staal's most frequent co-authors are Richard Ambinder, MD, Carmen Joseph Allegra, MD and Jerry Spivak, MD.

Dmand AI links Dr. Staal to 1 clinical trial. Conditions studied include Glioma and Neoplasms, Neuroepithelial.

CMS Open Payments shows 6 general payments to Dr. Staal from 4 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 97% of the total. Ipsen Biopharmaceuticals, Inc paid the most, $177.

Dmand AI lists 1 award for Dr. Staal, most recently CMS Stage 1 EHR in 2013.

Dr. Staal graduated from UC San Diego School of Medicine in 1972.

Dr. Staal is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.